1. European Medicines Agency (EMA). Guideline on similar biological medicinal products containing monoclonal antibodies–non-clinical and clinical issues. 2012b. EMA/CHMP/BMWP/403543/2010 [consultado 25 Ene 2015]. Disponible en: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500128686.pdf
2. EuropaBio. Guide to biological medicines. A focus on biosimilar medicines. 2011 [consultado 25 Ene 2015]. Disponible en: http://www.europabio.org/guide-biological-medicines-focus-biosimilar-medicines
3. European Commission. What you need to know about biosimilar medicinal products. A consensus information document. 2013 [consultado 25 Ene 2015]. Disponible en: http://ec.europa.eu/DocsRoom/documents/8242
4. European Medicines Agency's scientific guidelines on biosimilar medicines. [Consultado 25 Ene 2015]. Disponible en: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000408.jsp
5. Table with information on the reimbursement status of biosimilar medicinal products in EEA countries [consultado 25 Ene 2015]. Disponible en: http://ec.europa.eu/enterprise/sectors/healthcare/files/docs/biosimilars_reimbursement_en.pdf